HEADER HYDROLASE/HYDROLASE INHIBITOR 09-AUG-12 4GJ6 TITLE CRYSTAL STRUCTURE OF RENIN IN COMPLEX WITH NVP-AYZ832 (COMPOUND 6A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 67-406; COMPND 5 SYNONYM: ANGIOTENSINOGENASE; COMPND 6 EC: 3.4.23.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS RENIN INHIBITOR, PHARMACOPHORE SEARCH, TRANS-3, 4-DISUBSTITUTED KEYWDS 2 PYRROLIDINE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.OSTERMANN,F.ZINK,M.KROEMER REVDAT 5 06-NOV-24 4GJ6 1 REMARK REVDAT 4 13-SEP-23 4GJ6 1 HETSYN REVDAT 3 29-JUL-20 4GJ6 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 10-APR-13 4GJ6 1 JRNL REVDAT 1 06-MAR-13 4GJ6 0 JRNL AUTH E.LORTHIOIS,W.BREITENSTEIN,F.CUMIN,C.EHRHARDT,E.FRANCOTTE, JRNL AUTH 2 E.JACOBY,N.OSTERMANN,H.SELLNER,T.KOSAKA,R.L.WEBB,D.F.RIGEL, JRNL AUTH 3 U.HASSIEPEN,P.RICHERT,T.WAGNER,J.MAIBAUM JRNL TITL THE DISCOVERY OF NOVEL POTENT TRANS-3,4-DISUBSTITUTED JRNL TITL 2 PYRROLIDINE INHIBITORS OF THE HUMAN ASPARTIC PROTEASE RENIN JRNL TITL 3 FROM IN SILICO THREE-DIMENSIONAL (3D) PHARMACOPHORE JRNL TITL 4 SEARCHES. JRNL REF J.MED.CHEM. V. 56 2207 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23425156 JRNL DOI 10.1021/JM3017078 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.3 REMARK 3 NUMBER OF REFLECTIONS : 23575 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2377 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.33 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2412 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2209 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2163 REMARK 3 BIN R VALUE (WORKING SET) : 0.2119 REMARK 3 BIN FREE R VALUE : 0.2979 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 249 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5117 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 151 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.16680 REMARK 3 B22 (A**2) : 0.33520 REMARK 3 B33 (A**2) : 0.83160 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.278 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.071 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.300 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.851 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.301 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5399 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7327 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1783 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 111 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 788 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5399 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 717 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6090 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GJ6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074249. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 95.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97948 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23603 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 52.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 68.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2V0Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 18-21% PEG4000, 0.4-0.6 M REMARK 280 SODIUM CHLORIDE, 50 MM SODIUM CITRATE, PH 4-5, PROTEIN SOLUTION: REMARK 280 10-15 MG/ML PROTEIN, 25 MM SODIUM CHLORIDE, 12.5 MM TRIS, PH 8, REMARK 280 DROP: 1 UL PROTEIN SOLUTION + 1 UL RESERVOIR, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.50300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.18300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.46500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.18300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.50300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.46500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A -5 REMARK 465 ARG A 46A REMARK 465 LEU A 46B REMARK 465 TYR A 46C REMARK 465 SER A 158A REMARK 465 GLU A 158B REMARK 465 ASN A 158C REMARK 465 ARG B 46A REMARK 465 LEU B 46B REMARK 465 TYR B 46C REMARK 465 GLU B 159A REMARK 465 ASN B 159B REMARK 465 SER B 159C REMARK 465 GLN B 159D REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 51 -39.52 -34.96 REMARK 500 ASN A 67 -64.12 -146.70 REMARK 500 ASP A 149 49.20 -76.99 REMARK 500 ARG A 240 -169.36 -121.15 REMARK 500 ASN B 67 -63.50 -147.47 REMARK 500 ARG B 240 -166.67 -120.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GJ5 RELATED DB: PDB REMARK 900 RELATED ID: 4GJ7 RELATED DB: PDB DBREF 4GJ6 A -5 326 UNP P00797 RENI_HUMAN 67 406 DBREF 4GJ6 B -5 326 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG SEQRES 1 B 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 B 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 B 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 B 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 B 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 B 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 B 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 B 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 B 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 B 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 B 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 B 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 B 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 B 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 B 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 B 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 B 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 B 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 B 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 B 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 B 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 B 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 B 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 B 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 B 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 B 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 B 340 ALA ARG MODRES 4GJ6 ASN A 67 ASN GLYCOSYLATION SITE MODRES 4GJ6 ASN B 67 ASN GLYCOSYLATION SITE HET NAG A1000 14 HET 0LS A1001 27 HET 0LS A1002 27 HET SO4 A1003 5 HET NAG B1000 14 HET 0LS B1001 27 HET 0LS B1002 27 HET SO4 B1003 5 HET SO4 B1004 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 0LS N-{[(3S,4S)-4-BENZYLPYRROLIDIN-3-YL]METHYL}-4-CHLORO-N- HETNAM 2 0LS PHENYLANILINE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 0LS 4(C24 H25 CL N2) FORMUL 6 SO4 3(O4 S 2-) FORMUL 12 HOH *188(H2 O) HELIX 1 1 ALA A 49 HIS A 53 5 5 HELIX 2 2 ASP A 57 SER A 61 5 5 HELIX 3 3 PRO A 108 MET A 113 1 6 HELIX 4 4 PHE A 125 VAL A 133 5 9 HELIX 5 5 PRO A 135 GLN A 143 1 9 HELIX 6 6 ASP A 171 GLN A 173 5 3 HELIX 7 7 SER A 224 GLY A 236 1 13 HELIX 8 8 ASN A 250 LEU A 255 5 6 HELIX 9 9 THR A 270 VAL A 275 1 6 HELIX 10 10 GLY A 302 LYS A 308 1 7 HELIX 11 11 ALA B 49 HIS B 53 5 5 HELIX 12 12 ASP B 57 SER B 61 5 5 HELIX 13 13 PRO B 108 MET B 113 1 6 HELIX 14 14 PHE B 125 VAL B 133 5 9 HELIX 15 15 PRO B 135 GLN B 143 1 9 HELIX 16 16 ASP B 171 GLN B 173 5 3 HELIX 17 17 SER B 224 GLY B 236 1 13 HELIX 18 18 ASN B 250 LEU B 255 5 6 HELIX 19 19 THR B 270 VAL B 275 1 6 HELIX 20 20 GLY B 302 LYS B 308 1 7 SHEET 1 A 9 LYS A 65 TYR A 75 0 SHEET 2 A 9 GLY A 78 VAL A 91 -1 O GLY A 78 N TYR A 75 SHEET 3 A 9 GLN A 13 ILE A 20 -1 N GLY A 19 O THR A 90 SHEET 4 A 9 SER A 2 TYR A 9 -1 N TYR A 9 O GLN A 13 SHEET 5 A 9 GLY A 163 LEU A 167 -1 O LEU A 167 N SER A 2 SHEET 6 A 9 VAL A 150 TYR A 155 -1 N TYR A 154 O GLN A 164 SHEET 7 A 9 PHE A 309 ASP A 314 -1 O PHE A 313 N PHE A 151 SHEET 8 A 9 ARG A 319 ALA A 325 -1 O ARG A 319 N ASP A 314 SHEET 9 A 9 TYR A 175 ASN A 183 -1 N GLU A 176 O LEU A 324 SHEET 1 B13 LYS A 65 TYR A 75 0 SHEET 2 B13 GLY A 78 VAL A 91 -1 O GLY A 78 N TYR A 75 SHEET 3 B13 ILE A 94 GLU A 106 -1 O GLU A 103 N PHE A 83 SHEET 4 B13 VAL A 38 PRO A 41 1 N VAL A 38 O GLY A 102 SHEET 5 B13 GLY A 119 GLY A 122 -1 O VAL A 120 N TRP A 39 SHEET 6 B13 GLN A 25 ASP A 32 1 N VAL A 30 O VAL A 121 SHEET 7 B13 GLN A 13 ILE A 20 -1 N GLY A 16 O VAL A 29 SHEET 8 B13 SER A 2 TYR A 9 -1 N TYR A 9 O GLN A 13 SHEET 9 B13 GLY A 163 LEU A 167 -1 O LEU A 167 N SER A 2 SHEET 10 B13 VAL A 150 TYR A 155 -1 N TYR A 154 O GLN A 164 SHEET 11 B13 PHE A 309 ASP A 314 -1 O PHE A 313 N PHE A 151 SHEET 12 B13 ARG A 319 ALA A 325 -1 O ARG A 319 N ASP A 314 SHEET 13 B13 TYR A 175 ASN A 183 -1 N GLU A 176 O LEU A 324 SHEET 1 C 4 SER A 202 LEU A 205 0 SHEET 2 C 4 GLN A 191 VAL A 199 -1 N VAL A 197 O LEU A 205 SHEET 3 C 4 ILE A 258 LEU A 262 -1 O HIS A 261 N LYS A 195 SHEET 4 C 4 LYS A 265 LEU A 269 -1 O LEU A 269 N ILE A 258 SHEET 1 D 6 SER A 202 LEU A 205 0 SHEET 2 D 6 GLN A 191 VAL A 199 -1 N VAL A 197 O LEU A 205 SHEET 3 D 6 CYS A 210 VAL A 214 -1 O CYS A 210 N MET A 194 SHEET 4 D 6 TRP A 299 LEU A 301 1 O LEU A 301 N LEU A 213 SHEET 5 D 6 ILE A 221 GLY A 223 -1 N SER A 222 O ALA A 300 SHEET 6 D 6 ILE A 286 ALA A 288 1 O HIS A 287 N ILE A 221 SHEET 1 E 3 LYS A 238 LYS A 239 0 SHEET 2 E 3 TYR A 245 LYS A 248 -1 O VAL A 246 N LYS A 238 SHEET 3 E 3 LEU A 281D THR A 283 -1 O CYS A 282 N VAL A 247 SHEET 1 F 9 LYS B 65 TYR B 75 0 SHEET 2 F 9 GLY B 78 VAL B 91 -1 O VAL B 80 N LEU B 73 SHEET 3 F 9 GLN B 13 ILE B 20 -1 N GLY B 19 O THR B 90 SHEET 4 F 9 SER B 2 TYR B 9 -1 N TYR B 9 O GLN B 13 SHEET 5 F 9 GLY B 163 LEU B 167 -1 O LEU B 167 N SER B 2 SHEET 6 F 9 VAL B 150 TYR B 155 -1 N TYR B 154 O GLN B 164 SHEET 7 F 9 PHE B 309 ASP B 314 -1 O PHE B 313 N PHE B 151 SHEET 8 F 9 ARG B 319 ALA B 325 -1 O ARG B 319 N ASP B 314 SHEET 9 F 9 TYR B 175 ASN B 183 -1 N GLU B 176 O LEU B 324 SHEET 1 G13 LYS B 65 TYR B 75 0 SHEET 2 G13 GLY B 78 VAL B 91 -1 O VAL B 80 N LEU B 73 SHEET 3 G13 ILE B 94 GLU B 106 -1 O GLU B 103 N PHE B 83 SHEET 4 G13 VAL B 38 PRO B 41 1 N VAL B 38 O GLY B 102 SHEET 5 G13 GLY B 119 GLY B 122 -1 O VAL B 120 N TRP B 39 SHEET 6 G13 GLN B 25 ASP B 32 1 N VAL B 30 O VAL B 121 SHEET 7 G13 GLN B 13 ILE B 20 -1 N GLY B 16 O VAL B 29 SHEET 8 G13 SER B 2 TYR B 9 -1 N TYR B 9 O GLN B 13 SHEET 9 G13 GLY B 163 LEU B 167 -1 O LEU B 167 N SER B 2 SHEET 10 G13 VAL B 150 TYR B 155 -1 N TYR B 154 O GLN B 164 SHEET 11 G13 PHE B 309 ASP B 314 -1 O PHE B 313 N PHE B 151 SHEET 12 G13 ARG B 319 ALA B 325 -1 O ARG B 319 N ASP B 314 SHEET 13 G13 TYR B 175 ASN B 183 -1 N GLU B 176 O LEU B 324 SHEET 1 H 4 SER B 202 LEU B 205 0 SHEET 2 H 4 GLN B 191 VAL B 199 -1 N VAL B 197 O LEU B 205 SHEET 3 H 4 ILE B 258 LEU B 262 -1 O HIS B 261 N LYS B 195 SHEET 4 H 4 GLU B 266 LEU B 269 -1 O TYR B 267 N PHE B 260 SHEET 1 I 6 SER B 202 LEU B 205 0 SHEET 2 I 6 GLN B 191 VAL B 199 -1 N VAL B 197 O LEU B 205 SHEET 3 I 6 CYS B 210 VAL B 214 -1 O CYS B 210 N MET B 194 SHEET 4 I 6 TRP B 299 LEU B 301 1 O LEU B 301 N LEU B 213 SHEET 5 I 6 ILE B 221 GLY B 223 -1 N SER B 222 O ALA B 300 SHEET 6 I 6 ILE B 286 ALA B 288 1 O HIS B 287 N ILE B 221 SHEET 1 J 3 LYS B 238 LYS B 239 0 SHEET 2 J 3 TYR B 245 LYS B 248 -1 O VAL B 246 N LYS B 238 SHEET 3 J 3 LEU B 281D THR B 283 -1 O CYS B 282 N VAL B 247 SSBOND 1 CYS A 45 CYS A 50 1555 1555 2.03 SSBOND 2 CYS A 206 CYS A 210 1555 1555 2.05 SSBOND 3 CYS A 249 CYS A 282 1555 1555 2.06 SSBOND 4 CYS B 45 CYS B 50 1555 1555 2.04 SSBOND 5 CYS B 206 CYS B 210 1555 1555 2.04 SSBOND 6 CYS B 249 CYS B 282 1555 1555 2.05 LINK ND2 ASN A 67 C1 NAG A1000 1555 1555 1.44 LINK ND2 ASN B 67 C1 NAG B1000 1555 1555 1.44 CISPEP 1 THR A 22 PRO A 23 0 -3.09 CISPEP 2 LEU A 110 PRO A 111 0 3.31 CISPEP 3 PRO A 293 PRO A 294 0 5.04 CISPEP 4 GLY A 296 PRO A 297 0 -0.87 CISPEP 5 THR B 22 PRO B 23 0 -4.82 CISPEP 6 LEU B 110 PRO B 111 0 2.42 CISPEP 7 PRO B 293 PRO B 294 0 5.36 CISPEP 8 GLY B 296 PRO B 297 0 -3.06 CRYST1 67.006 110.930 130.366 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014924 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009015 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007671 0.00000